Cargando…
Synthesis of a Vpr-Binding Derivative for Use as a Novel HIV-1 Inhibitor
The emergence of multidrug-resistant viruses compromises the efficacy of anti-human immunodeficiency virus type 1 (HIV-1) therapy and limits treatment options. Therefore, new targets that can be used to develop novel antiviral agents need to be identified. We previously identified a potential parent...
Autores principales: | Hagiwara, Kyoji, Ishii, Hideki, Murakami, Tomoyuki, Takeshima, Shin-nosuke, Chutiwitoonchai, Nopporn, Kodama, Eiichi N., Kawaji, Kumi, Kondoh, Yasumitsu, Honda, Kaori, Osada, Hiroyuki, Tsunetsugu-Yokota, Yasuko, Suzuki, Masaaki, Aida, Yoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689350/ https://www.ncbi.nlm.nih.gov/pubmed/26701275 http://dx.doi.org/10.1371/journal.pone.0145573 |
Ejemplares similares
-
Huntingtin-Interacting Protein 1 Promotes Vpr-Induced G2 Arrest and HIV-1 Infection in Macrophages
por: Murakami, Tomoyuki, et al.
Publicado: (2021) -
HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release
por: Chutiwitoonchai, Nopporn, et al.
Publicado: (2016) -
HIV-1 Vpr Induces Interferon-Stimulated Genes in Human Monocyte-Derived Macrophages
por: Zahoor, Muhammad Atif, et al.
Publicado: (2014) -
Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development
por: Chutiwitoonchai, Nopporn, et al.
Publicado: (2017) -
The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells
por: Nonaka, Mizuho, et al.
Publicado: (2009)